What is Exagen Inc.'s SG&A?

Exagen Inc. (XGN) reported SG&A of $12.07M in Q1 2026.

How has Exagen Inc.'s SG&A changed year-over-year?

Exagen Inc.'s SG&A increased by 7.7% year-over-year, from $11.2M to $12.07M.

What is the long-term trend for Exagen Inc.'s SG&A?

Over 4 years (2021 to 2025), Exagen Inc.'s SG&A has grown at a 1.1% compound annual growth rate (CAGR), from $44.54M to $46.62M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Exagen Inc. XGN SG&A

SG&A at other companies

Labcorp HoldingsLH

$551M+0.9%

Quest DiagnosticsDGX

$504M+5.9%

Bio-Rad LaboratoriesBIO

$212.4M+1.7%

RevvityRVTY

$253.88M+1.7%

Agilent TechnologiesA

$465M+2.4%

Biodesix, Inc.BDSX

$24.26M+18.6%

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s SG&A?: Exagen Inc. (XGN) reported SG&A of $12.07M in Q1 2026.
How has Exagen Inc.'s SG&A changed year-over-year?: Exagen Inc.'s SG&A increased by 7.7% year-over-year, from $11.2M to $12.07M.
What is the long-term trend for Exagen Inc.'s SG&A?: Over 4 years (2021 to 2025), Exagen Inc.'s SG&A has grown at a 1.1% compound annual growth rate (CAGR), from $44.54M to $46.62M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.